View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

Transactions in Connection with Share Buy-back Program

Transactions in Connection with Share Buy-back Program Company Announcement COPENHAGEN, Denmark; March 2, 2026 – Genmab A/S (Nasdaq: GMAB). On February 17, 2026, Genmab announced the initiation of a share buy-back program to repurchase up to 342,130 shares with a maximum aggregate total value of DKK 725 million to honor our commitments under the Restricted Stock Unit program. The share buy-back program is expected to be completed no later than March 31, 2026. The following transactions were executed under the program from February 23 to February 27, 2026:  No. of sharesAverage price (DKK...

 PRESS RELEASE

Transactions with shares and linked securities in Genmab A/S made by m...

Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons Company Announcement COPENHAGEN, Denmark; February 27, 2026 – (Nasdaq: GMAB) - In accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523, this document discloses the data of the transactions made in Genmab A/S (Nasdaq: GMAB) by managerial employees and their closely associated persons. The company’s managerial employees and their closely associated persons have given Genmab A/S power of attorney on their behalf ...

 PRESS RELEASE

Grant of Restricted Stock Units to Management and Employees and Grant ...

Grant of Restricted Stock Units to Management and Employees and Grant of Warrants to Employees in Genmab Company Announcement COPENHAGEN, Denmark; February 27, 2026 – (Nasdaq: GMAB) announced today that the Board of Directors decided to grant 587,495 restricted stock units to members of management and employees of the Company as well as the Company's subsidiaries and 455,004 warrants to employees of the Company and the Company's subsidiaries. Each restricted stock unit is awarded cost-free and provides the owner with a conditional right to receive one share in Genmab A/S of nominally DKK...

 PRESS RELEASE

Safe Bulkers, Inc. to Participate in the Dry Bulk Shipping Panel at th...

Safe Bulkers, Inc. to Participate in the Dry Bulk Shipping Panel at the DNB Carnegie Energy & Shipping Conference in Oslo MONACO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Safe Bulkers, Inc. (NYSE: SB) (the “Company”), an international provider of marine drybulk transportation services, announced its participation in the Dry Bulk Shipping Panel at the annual DNB Carnegie Energy & Shipping Conference, to be held in Oslo, Norway, on Wednesday, March 4 and Thursday, March 5, 2026. This top-tier Nordic event connects listed companies with capital markets, offering insights into market trends and ind...

 PRESS RELEASE

Genmab to Participate in Upcoming Investor Conferences

Genmab to Participate in Upcoming Investor Conferences Media ReleaseCOPENHAGEN, Denmark; February 25, 2026 (Nasdaq: GMAB) announced today that members of its Executive Committee will participate in fireside chats at the following investor conferences in March 2026:  TD Cowen 46th Annual Healthcare Conference in Boston on March 3, 2026, 9:10 AM EST (3:10 PM CET)Leerink Global Healthcare Conference in Miami on March 10, 2026, 8:40 AM EDT (1:40 PM CET)Barclays 28th Annual Global Healthcare Conference in Miami on March 11, 2026, 1:30 PM EDT (6:30 PM CET) The live and archived webcast of the p...

 PRESS RELEASE

Capital Increase in Genmab as a Result of Employee Warrant Exercise

Capital Increase in Genmab as a Result of Employee Warrant Exercise Company Announcement COPENHAGEN, Denmark; February 24, 2026 – (Nasdaq: GMAB) will increase its share capital by 12,313 shares as a consequence of the exercise of employee warrants. The increase is effected without any preemption rights for the existing shareholders of the company or others. The shares are subscribed in cash at the following price per share of nominally DKK 1: 710 shares at DKK 1,147.50,239 shares at DKK 1,155.00,1,527 shares at DKK 1,161.00,1,183 shares at DKK 1,334.50,5,391 shares at DKK 1,362.50, and3...

ABGSC Healthcare Research ... (+2)
  • ABGSC Healthcare Research
  • Georg Tigalonov-Bjerke

Teekay Tankers Ltd: 1 director

A director at Teekay Tankers Ltd sold 1,050 shares at 70.821USD and the significance rating of the trade was 55/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...

 PRESS RELEASE

Transactions in Connection with Share Buy-back Program

Transactions in Connection with Share Buy-back Program Company Announcement COPENHAGEN, Denmark; February 23, 2026 – Genmab A/S (Nasdaq: GMAB). On February 17, 2026, Genmab announced the initiation of a share buy-back program to repurchase up to 342,130 shares with a maximum aggregate total value of DKK 725 million to honor our commitments under the Restricted Stock Unit program. The share buy-back program is expected to be completed no later than March 31, 2026. The following transactions were executed under the program from February 18 to February 20, 2026:  No. of sharesAverage price ...

 PRESS RELEASE

Transactions with shares and linked securities in Genmab A/S made by m...

Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons Company Announcement COPENHAGEN, Denmark; February 20, 2026 – (Nasdaq: GMAB) - In accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523, this document discloses the data of the transactions made in Genmab A/S (Nasdaq: GMAB) by managerial employees and their closely associated persons. The company’s managerial employees and their closely associated persons have given Genmab A/S power of attorney on their behalf ...

 PRESS RELEASE

Safe Bulkers, Inc. Reports Fourth Quarter 2025 Results and Declares Di...

Safe Bulkers, Inc. Reports Fourth Quarter 2025 Results and Declares Dividend on Common Stock MONACO, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Safe Bulkers, Inc. (the "Company") (NYSE: SB), an international provider of marine drybulk transportation services, announced today its unaudited financial results for the three and twelve-month periods ended December 31, 2025. The Board of Directors (the "Board") of the Company also declared a cash dividend of $0.05 per share of outstanding common stock. Financial highlights      In million U.S. Dollars except per share dataQ4 2025Q3 2025Q2 2025Q1 2025Q4 ...

 PRESS RELEASE

Teekay Tankers Ltd. Reports Fourth Quarter and Annual 2025 Results and...

Teekay Tankers Ltd. Reports Fourth Quarter and Annual 2025 Results and Declares Dividend HAMILTON, Bermuda, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Teekay Tankers Ltd. (Teekay Tankers or the Company) (NYSE: TNK) today reported the Company's results for the three months and year ended December 31, 2025, and announced that its Board of Directors has declared its regular, fixed quarterly cash dividend of $0.25 per share for the quarter ended December 31, 2025. The cash dividend is payable on March 13, 2026 to all shareholders of record as at March 2, 2026. The full earnings release and Teekay Gro...

 PRESS RELEASE

Notice to Convene the Annual General Meeting of Genmab A/S

Notice to Convene the Annual General Meeting of Genmab A/S Company Announcement Genmab A/S to hold Annual General Meeting on Thursday March 19, 2026 COPENHAGEN, Denmark; February 18, 2026 – (Nasdaq: GMAB) summons the Annual General Meeting on Thursday, March 19, 2026, at 2:00 PM CET at the Copenhagen Marriott Hotel, Kalvebod Brygge 5, DK-1560 Copenhagen V, Denmark. The notice for the Annual General Meeting, including Appendix 1: Candidates for the Board of Directors, is attached.  About Genmab Genmab is an international biotechnology company dedicated to improving the lives of people ...

 PRESS RELEASE

Genmab Announces Initiation of Share Buy-Back Program

Genmab Announces Initiation of Share Buy-Back Program Company Announcement Repurchase of up to 342,130 shares with a maximum aggregate total value of 725 million DKK Honoring our commitments under the Restricted Stock Unit programCompletion expected no later than March 31, 2026 COPENHAGEN, Denmark; February 17, 2026 – (Nasdaq: GMAB) announced today that it is initiating a share buy-back program, to honor our commitments under the Restricted Stock Unit program. The share buy-back program will be undertaken on the terms set out below and in accordance with Regulation (EU) No. 596/2014 (‘M...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch